Manuscripts

Search by keyword, year, or author name.

Showing 1589 manuscripts.

Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus

K. Dascomb, Rebecca Adair Clark, Judith A. Aberg, Joseph J. Pulvirenti, Ross G. Hewitt, Patty Kissinger, Elizabeth Didier. Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus. Journal of Clinical Microbiology. 1999. 37: 3421-2.

Year

1999

Journal

Journal of Clinical Microbiology

Absolute Copy Number and Relative Change in Determinations of Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an External Standard on Kit Comparisons.

Donald Brambilla, Sheila Leung, Judy Lew, John Todd, Steven Herman, Mike Cronin, David E. Shapiro, James Bremer, Celine Hanson, George V. Hillyer, George D. McSherry, Rhoda S. Sperling, Robert W. Coombs, Patricia S. Reichelderfer. Absolute Copy Number and Relative Change in Determinations of Human Immunodeficiency Virus Type 1 RNA in Plasma: Effect of an External Standard on Kit Comparisons.. Journal of Clinical Microbiology. 1998. 36: 311-314.

Year

1998

Journal

Journal of Clinical Microbiology

Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy

Judith A. Aberg, David M. Yajko, Mark A. Jacobson. Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. Journal of Infectious Diseases. 1998. 178: 1446-9.

Year

1998

Journal

Journal of Infectious Diseases

Human immunodeficiency virus type 1 RNA shedding in the female genital tract

Claudia Goulston, W. McFarland, David Katzenstein. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases. 1998. 177: 1100-3.

Year

1998

Journal

Journal of Infectious Diseases

Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA

Patricia Reichelderfer, Anthony Japour, Lisa M. Demeter, Richard D'Aquila, Owen Weislow, Alejo Erice, Joseph Fitzgibbon, Robert Shafer, Douglas Richman, Yuqi Zhao, Diana Huang, Douglas Mayers, Max Arens, Kim Sannerud, Suraiya Rasheed, Daniel Kuritzkes. Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA. Journal of Virological Methods. 1998. 75: 93-104.

Year

1998

Journal

Journal of Virological Methods

Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS

G. Widmer, S. Tzipori, Carl J. Fichtenbaum, Jeff Griffiths. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. Journal of Infectious Diseases. 1998. 178: 834-40.

Year

1998

Journal

Journal of Infectious Diseases

Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076

P. S. Eastman, David E. Shapiro, Robert W. Coombs, Lisa M. Frenkel, George D. McSherry, Paula Britto, Steven A. Herman, Rhoda S. Sperling. Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076. Journal of Infectious Diseases. 1998. 177: 557-64.

Year

1998

Journal

Journal of Infectious Diseases

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection

Frank Palella, K. M. Delaney, A. C. Moorman, Mark O. Loveless, Jack Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998. 338: 853-60.

Year

1998

Journal

New England Journal of Medicine

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor

David J. Straus, Jenny Huang, Marcia A. Testa, Alexandra M. Levine, Lawrence D. Kaplan. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology. 1998. 16: 3601-6.

Year

1998

Journal

Journal of Clinical Oncology

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group

Genevieve Chene, Philippe Morlat, Catherine Leport, Richard Hafner, L. Dequae, I. Charreau, Jean-Pierre Aboulker, Benjamin J. Luft, Jean Aubertin, Jean-Louis Vilde, Roger Salamon. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group. Controlled Clinical Trials. 1998. 19: 233-48.

Year

1998

Journal

Controlled Clinical Trials